• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
    • Just look at what our Tens of Thousands of Satisfied Customers say about us
    Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Cipla > November 18, 2009

      Cipla launches drug to treat Swine flu virus

      Posted AtNDTV PROFITS

      A few years back, he invited the ire of his global competitors by launching the anti-AIDS cocktail and now the "generic drugs maverick" K Hamied, the CMD of Cipla, is back with his affordable alternative for the recent pandemic H1N1.

      Drugmaker Cipla on Wednesday launched its generic version of Roche's Tamiflu, used in the treatment of the H1N1 swine flu virus. The drug has been cleared by the WHO cleared and it will now be available in select drug stores in India.

      And his plans are clear: to tap the export market for his generic version of Roche’s Tamiflu that Cipla is marketing under the brand name "Antiflu". The drug maker said it has offered to supply Cipla's Oseltamivir brand to the Unites States.

      YK Hamied, CMD of Cipla, said, "Apparently, there is a shortage there. We have offered and it is now up to them. We can produce 2 million doses of Oseltamivir a month if needed."

      Cipla has so far made $10 million in revenues by exporting this drug to countries in Latin America, Africa and some parts of the Middle East and the South East Asia. The patent protection regime in the US and Europe has kept the company for exploiting these markets but Cipla is hoping to see them open up.

      Even as it faces tough competition in the domestic space from players like Hetero Drugs, Strides Arcolab, Natco Pharma and Ranbaxy Lab, Cipla's top man is sticking to his time tested formula for growth by pushing up exports. But will the H1N1 generic drug replicate the success of Cipla's anti-Aids drug will depend on how hostile the competitors are towards this launch.


      November 18, 2009


       

      Share this Article!

    Back to top^